Recent studies reveal that several super-enhancer harboring transcription factors including HAND2, ISL1, PHOX2B, GATA3, and TBX2 constitute a CRC that is essential for the MYCN expression and the survival of MYCN-amplified neuroblastoma cells (61, 87). This evidence concerns the gene MYCN and neuroblastoma.